Cargando…
Long-Term Outcomes of the 150 mm Drug-Coated Balloon Cohort from the IN.PACT Global Study
PURPOSE: Data on the long-term safety and effectiveness of drug-coated balloons (DCBs) for the treatment of long femoropopliteal atherosclerotic lesions in the real-world setting are rare. This study reports 3 year and 5 year outcomes of the pre-specified 150 mm balloon sub-cohort of the IN.PACT Glo...
Autores principales: | Brodmann, Marianne, Lansink, Wouter, Guetl, Katharina, Micari, Antonio, Menk, Jeremiah, Zeller, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458561/ https://www.ncbi.nlm.nih.gov/pubmed/35864209 http://dx.doi.org/10.1007/s00270-022-03214-y |
Ejemplares similares
-
Five-Year Outcomes after Paclitaxel Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Diabetic and Chronic Limb-Threatening Ischemia Cohorts: IN.PACT Global Study Post Hoc Analysis
por: Reijnen, Michel M. P. J., et al.
Publicado: (2023) -
Drug-Coated Balloon Treatment of Femoropopliteal Lesions Typically Excluded From Clinical Trials: 12-Month Findings From the IN.PACT Global Study
por: Ansel, Gary M., et al.
Publicado: (2018) -
Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial
por: Schneider, Peter A., et al.
Publicado: (2018) -
Long‐term outcomes after paclitaxel‐coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study
por: Ko, Young‐Guk, et al.
Publicado: (2022) -
IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population
por: Chen, Zhong, et al.
Publicado: (2019)